Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
Submitted: 17 July 2016
Accepted: 11 October 2016
Published: 16 December 2016
Accepted: 11 October 2016
Abstract Views: 2875
PDF: 708
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.